• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Recordati Makes New Appointments Following Death of CEO


August 17, 2016

Following the death of its Chairman and Chief Executive Officer Giovanni Recordati this week, the board of Recordati (Milan, Italy)  appointed Alberto Recordati as Chairman of the Board of Directors and Andrea Recordati as Vice Chairman and Chief Executive Officer.

Andrea has been Chief Operating Officer since 2013, in charge of the group’s commercial and production activities. Alberto Recordati has been responsible for drug discovery and development activities since 2008 and  for licensing-in activities since 2011.

Giovanni Recordati had been Chief Executive Officer of the company since 1990.

Recent Videos
Related Content